The Oro Organization, LLC Partners with Medical Hair Restoration to Launch New Website USHairRepla... ( The Oro Orga...)

The Oro Organization, LLC Partners with Medical Hair Restoration to Launch New Website USHairReplacement.com

Date:5/21/2009

The Oro Organization, LLC, an online lead generation company, announced today a partnership with Medical Hair Restoration.

Delray Beach, FL (PRWEB) May 21, 2009 -- The Oro Organization, LLC, an online lead generation company, announced today a partnership with Medical Hair Restoration. "With the launch of our newest web property, USHairReplacement.com, we wanted to partner with one of the industry leaders in the hair loss solutions industry." said Ian Shiell, Founder of The Oro Organization, LLC.

The combination of USHairReplacement.com and Medical Hair Restoration will provide a powerhouse for online lead generation and hair replacement. Mr. Shiell explained, "We expect great synergies between these two companies. Our focus is to ensure that the consumer looking online for hair restoration cost and information gets accurate information, and gets it fast."

Medical Hair Restoration has over 60 consultation offices nationwide. With 22 hair restoration surgeons, MHR is the 2nd largest hair transplantation company in the country. As one of the leaders in hair loss solutions, MHR has performed over 100,000 hair restoration procedures for patients all over the world.

The founder and current medical director of Medical Hair Restoration, Dr. Matt Leavitt, is a recognized authority on hair transplantation. Dr. Leavitt personally selects and trains the MHR physicians based on their medical skill and artistic expertise. The direct involvement that Dr. Leavitt has in MHR has helped solidify it as a national franchise, and contributed directly to their acceptance into USHairReplacement's net
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Chiltern Announces Acquisition of an Independent USA Based Clinical Research Organization, Clinical Trial Management Services, Inc.
2. Training and experience can affect brain organization, research shows
3. New Dermatology Nurses Association President Fairbrother to Work to Increase Visibility of Organization, Profession
4. Dr. Said Hakki, President of Iraqi Red Crescent Organization, in the United States and Available for Interviews May 12-16
5. The Risk Management and Patient Safety Institute Announces Agreement With Pioneering Health Care Simulation Organization, PSO One
6. Leading German Health Insurance Organization, Deutsche Angestellten-Krankenkasse (DAK), Standardizes on Jive Software to Harness Employee Knowledge
7. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
8. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
9. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
10. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
11. AtriCure to Present at Roth Capital Partners 2007 New York Conference

Post Your Comments:

(Date:11/25/2009)...oadPoliticalEndorsements,Business,andPressJoinEffo...-USNewswire/--Onceagain,theNationalBipolarFoundati...dorsingtheir"Safe,tilStable"program,whichisnowbein...polardisorder.Today,theNationalBipolarFoundationre...riorityMailfromtheLt.GovernorofLouisianaMitchLandr...

(Date:11/25/2009)...itous discovery that grew out of a collaboration b...ally offer hope to the nearly 10 million Americans..., Also known as hardening of the arteries, perip...atory problem in which narrowed arteries reduce bl... a red flag for vascular disease, heart attack and...

(Date:11/25/2009)...already used to fight rheumatoid arthritis, could ... , WEDNESDAY, Nov. 25 (HealthDay News) -- A d...and rheumatoid arthritis now also shows some promi... diabetes. , The drug, rituximab (Rituxan), hel...lin, even though the disease had destroyed some of...

(Date:11/25/2009)...ften plagued by neurological symptoms, study finds...) -- Neurological side effects are among the poten...icular cancer who were treated with cisplatin-base...udy included 1,409 Norwegian men treated for unila...took part in a follow-up survey conducted from 199...

(Date:11/25/2009)...INGTON,Va.,Nov.25/PRNewswire-USNewswire/--TheAmeri...lthCareFraudActof2009,"S.2128,whichisdesignedtosub...ntfraudinMedicare.ThebillwasintroducedbySen.George...alprovisionstheAmericanAssociationforHomecareoutli...iationproposedtoCongressinFebruary.Thoseprovisions...

Breaking Medicine News(10 mins):Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2 Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3 Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2 Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3 Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4 Health News:Type 1 Diabetes May Have a New Foe 2 Health News:Type 1 Diabetes May Have a New Foe 3 Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2

[0] First Time-Door is Open for Family Discussion of Bipolar Disorder [1] Engineers, doctors at UCLA develop novel material that could help fight arterial disease [1] Type 1 Diabetes May Have a New Foe [0] Long-Term Problems Linked to Testicular Cancer Chemo [1] American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009'

... PfP Launches Ad Campaign C...uot; , Washington, DC (PR...hip for Prevention said today that President-elect...Accordingly, the organization launched an ad campa...

...ference Call Scheduled for Today - Thursday, Novem... Eastern Time, MOUNTAIN VIEW, Calif., Nov. 6 Ale...d today financial results for,the quarter and nine...od ended September 30, 2008, as reported in accord...

...rterly Revenue Exceeds $10 Million Company Delive...ber, BEDFORD, Mass., Nov. 6 Insulet Corporation,...ogy with its OmniPod(R),Insulin Management System,...n compared to,$3.8 million in the third quarter of...

...ROCHESTER, Minn. - Mayo Clinic researchers say the...sonalized care for a common blood cell cancer. The... along with two targeted treatments significantly ...Oct. 15 in the journal Cancer , found that in a s...

...FAIRFAX, Va. A two-year study conducted by researc...pital and the National Cancer Institute may open t...eases associated with obesity, a condition that af...n from morbidly obese patients undergoing weight l...

... Diego, Nov. 6 ResMed Inc. (NYSE: RMD ),today an...quarter ended,September 30, 2008. Revenue for the ...e quarter ended September 30, 2007. For the curren...r,ended September 30, 2007. Diluted earnings per s...

Obama's Call for "Change We Can Believe In" Makes Prevention a Priority in Health Reform Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates Insulet Reports Third Quarter 2008 Results Researchers find predictive tests and early treatment delay progression of blood cell cancer Melanin production discovered in fat tissue ResMed Inc Announces Record Financial Results for the Quarter Ended September 30, 2008

(Date:11/25/2009)...WICK,N.J.,Nov.25/PRNewswire/--SwissrayInternationa...hy( ddR )systems,announcedtodaythatitsoperationsha...viewtowardsgrowingSwissray,smedicalimagingbrand.Th...ty,aswellascontractsandinventory.After25yearsofsuc...eloftechnologicaladvancementswithstableandsteadygr...

(Date:11/25/2009)...Nov.25/PRNewswire-FirstCall/--NuVasive,Inc.(Nasdaq...roductsforminimallydisruptivesurgicaltreatmentsfor...llonMonday,November30,2009,at5:30p.m.ET/2:30p.m.PT...toreimbursementfortheCompany,sproductsandwillinclu...danswersession.Thedial-innumbersare1-877-407-4018f...

(Date:11/25/2009)...ov.25/PRNewswire/--Reportlinker.comannouncesthatan..., PainManagement-GlobalTrends ,, http:/...lobal-Trends.html ,, Widespreadavailabilityofg...eadventofnewdrugshaveacceleratedthepaceofgrowthint...sementstructurecontinuetoshapedemandforservices,dr...

Breaking Medicine Technology:Swissray International Announces New Ownership 2 NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2 NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3 Reportlinker Adds Pain Management - Global Trends 2 Reportlinker Adds Pain Management - Global Trends 3 Reportlinker Adds Pain Management - Global Trends 4 Reportlinker Adds Pain Management - Global Trends 5 Arpida Reports Interim Results For Six Months to 30 June 2009 13631 1 Arpida Reports Interim Results For Six Months to 30 June 2009 13631 2 Detecting bias in the reporting of clinical trials 54860 1 Researchers boost production of biofuel that could replace gasoline 9616 1 Researchers boost production of biofuel that could replace gasoline 9616 2

[0] Swissray International Announces New Ownership [0] NuVasive Announces Conference Call and Webcast Regarding Reimbursement [0] Reportlinker Adds Pain Management - Global Trends

...n highly potent DPP-4 inhibitor, possessing Ki of ...ph Pharmaceuticals,Inc., a privately held drug di... the results of its potent, smart DPP-4 inhibitor,...erican Diabetes,Association meeting in Chicago, Il...remely long acting, potent inhibitor of DPP-4 and,...

...Change Reported Unlike What Is Commonly Seen In,In...FirstCall/ -- Novo Nordisk,today announced results...ty and efficacy of insulin Levemir(R) (insulin det...2 diabetes were able,to adjust their own dosage of...r, comparable to dosing adjusted by their primary ...

Other Medicine Technology:Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 2 Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 3 Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 4 New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 2 New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 3 New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 4 New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 5

Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir

...ed on the TrueView II design, a new generation of ...roscopy is available. The new telescope class is f...us advanced fibre technology. For the surgeon, the...t colour reproduction, high resolution and ergonom...

Small Joint Arthroscopes

...AR Technology, which transforms traditional ultras...hnology dramatically reduces the amount of phaco e...full ultrasound cutting efficiency. Surgeons hav...d efficiently to the phaco tip, in a phenomenon th...

AMO Vitrax (sodium hyaluronate) viscoelastic solution

Medicine Products:

Mini-TrueView Arthroscopes Small Joint Arthroscopes Sovereign with WhiteStar Cold Phaco Technology AMO Vitrax (sodium hyaluronate) viscoelastic solution

The Oro Organization, LLC Partners with Medical Hair Restoration to Launch New Website USHairRepla...( The Oro Orga...),Health